Halberd Achieves Landmark Selective Elimination of Tau From an Antigen Mixture
Tau has been shown to be important in the development of Alzheimer's Disease.Eradication of tau accomplished without reducing levels of...
Year: 2022
Psyched Wellness Announces Launch of New Logo, Branding, and Website, Prepares to Release Industry-First Amanita Muscaria Tincture
Toronto, Ontario--(Newsfile Corp. - February 1, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Model N Announces New SaaS Solution for Pharmaceutical and Biotech Companies to Address State Price Transparency Mandates
Revenue Management Leader Helps Life Sciences Companies Operationalize Price Transparency Processes and Adapt to New Market-Driven Demands SAN MATEO, Calif.--(BUSINESS...
Huntzinger and Speare Partner to Implement and Support Meditech Expanse
DUNMORE, Pa.--(BUSINESS WIRE)--Huntzinger Management Group, Inc. (Huntzinger), a leader in healthcare IT advisory, managed, implementation and staffing services and a...
Glaukos Corporation to Release Fourth Quarter and Full Year 2021 Financial Results after Market Close on February 22
Conference Call and Webcast Scheduled for 1:30 p.m. PST SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology...
Hologic Launches First-Ever National Advertising Campaign Featuring Mary J. Blige
--Leader in women’s health shines spotlight on preventive screenings in commercial created by women, for women premiering during one of...
Axonics® to Participate in SVB Leerink Virtual Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
XPhyto Executes Covid-ID Lab Sales Contracts with Test Clinics and Pharmacies in Germany as Part of Multi-Product Rollout Strategy
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / February 1, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")...
Relief Announces That Collaboration Partner, Acer Therapeutics, was Issued U.S. Patent 11,202,767 Covering ACER-001 Methods of Use for Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
GENEVA, SWITZERLAND / ACCESSWIRE / February 1, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to...
Systemic Therapeutics Announces the Appointment of Its Executive Team
Hamilton, Ontario--(Newsfile Corp. - January 31, 2022) - Systemic Therapeutics Corp. (the "Company" or "SystemicTx") is a pre-clinical stage, biotechnology...
NHI Provides $28.5 Million Development Loan and Expands Encore Senior Living Relationship
MURFREESBORO, TN / ACCESSWIRE / January 31, 2022 / National Health Investors, Inc. (NYSE:NHI) today announced that it will fund...
Eversio Wellness Announces Inclusion on Health Canada’s List of Licensed Psilocybin Producers
SURREY, BC / ACCESSWIRE / January 31, 2022 / Eversio Wellness Ltd. ("Eversio" or the "Company"), a Canadian mushroom wellness...
Neutra’s Aggressive 2022 Strategy Roars Out of the Gates in Quick-Paced January
KATY, TX / ACCESSWIRE / January 31, 2022 / Neutra Corp. (OTC PINK:NTRR) reports that it has kicked off 2022...
Health Systems Gain Competitive Advantage with Tech Enhancements to IT Financial Processes
By Shannon Burke, Senior Vice President and General Manager of Health Systems, Synchrony Health & Wellness Health systems are facing...
RapidAI Announces Karim Karti as New CEO
Former GE Healthcare Imaging and iRhythm leader joins pioneers in clinical decision making and patient care coordination to support continued...
Netsmart myUnity® Achieves Industry First 100% ONC Health IT Certification
The industry’s first base criteria ONC-certified EHR enables palliative care providers to participate in quality incentive programs and alternative payment...
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax
Approval based on a comprehensive submission package including efficacy and safety data approximately six months after second doseSPIKEVAX has received...
Aytu BioPharma Completes $15 Million Debt Refinancing
ENGLEWOOD, CO / ACCESSWIRE / January 31, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and...
Eve & Co Announces Shares for Debt Transaction
STRATHROY, Ontario, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE;...
Veru Announces FDA Grant of Fast Track Designation for Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
-- Phase 3 Sabizabulin COVID-19 Clinical Study for Treatment of Hospitalized Moderate to Severe COVID-19 Patients at High Risk for...